Vitamin A derivatives (retinoids) play a key role in mammalian development and cell differentiation. Isomers of retinoic acid, the main active metabolite of vitamin A, activate retinoid receptors that act as ligand-dependent transcription factors and affect gene expression. White and brown adipose tissues are major sites of storage of vitamin A derivatives and they play an active role in whole body metabolism of retinoids. Moreover, adipose tissues are targets for the action of retinoic acid. In most cases retinoic acid impairs adipocyte differentiation although its ®nal effects on adipose tissue development depend on retinoic acid concentration, isomers availability and expression of retinoid receptor subtypes in the white or brown adipocyte. Retinoic acid (RA) has a speci®c effect on brown adipose tissue, because it activates transcription of the gene for uncoupling protein-1, responsible for brown fat thermogenesis.
Introduction
Vitamin A and its structural derivatives (retinoids) exert profound effects on vision, embryonic development, reproduction, haematopoiesis, and the regulation and differentiation of mammalian epithelial and mesenchymal cells. Other than in vision, most of these effects occur through retinoic acid (RA), the main active metabolite derived from vitamin A by enzymatic oxidation of retinol. Two isomers of RA, alltrans RA and 9-cis RA, are biologically active and most of the cells studied to date can convert either of the RA isomers into the other. The biological effects of RA isomers involve the activation of ligand-dependent transcription factors, the retinoid receptors. These belong to the nuclear receptor superfamily, which includes the steroid, vitamin D (VDR) and T 3 receptors (T 3 R), the peroxisome proliferator-activated receptors (PPARs) and a number of orphan receptors whose ligands are unknown. Indeed, two different subfamilies of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid-X receptors (RXRs) mediate the actions of RA isomers. Alltrans-RA in¯uences gene expression by activating the RAR moiety of RARaRXR heterodimers that bind RA response elements. 9-cis-RA is considered as a`pan-agonist': it binds RAR and RXR, and in¯uences gene expression by activating RAR (in the same way as all-trans-RA), but also by activating RXR when it interacts with target genes as an RXR homodimer or as a heterodimer of RXR and some members of the nuclear receptor superfamily, for example, PPARs. In contrast, when RXR heterodimerizes with VDR and T 3 R, the action of 9-cis-RA on the RXR moiety is suppressed. With respect to RARaRXR heterodimers, the ligand-induced transcriptional activation for RXR remains controversial. Besides the existence of two isomers of RA, whose synthesis might be differentially regulated, additional levels of complexity in the RA signalling pathway must be considered. Both the RAR and the RXR subfamilies are composed of three different subtypes, a, b and g, which are encoded by different genes and show characteristic developmental-and tissue-speci®c regulated expression (for reviews see Refs 1,2). Furthermore, a cross-talk between the RA signalling pathway and signalling pathways mediated by cellsurface receptors has been postulated. 3 A diagram of the major mechanisms of action for RA on gene expression is shown in Figure 1 .
Retinoids in adipose tissues
There are two kinds of adipose tissue in mammals, with different physiological roles. White adipose tissue (WAT) stores energy in the form of triacylglycerols. Brown adipose tissue (BAT) in contrast, is the main site of non-shivering thermogenesis. This function of BAT is due to uncoupling protein-1, a natural uncoupler of the oxidative phosphorylation system present exclusively in BAT mitochondria. At least in rodents, high activity of BAT correlates negatively with the development of obesity, that is, an increase in WAT mass (for a recent review see Ref. 4 ). In addition, both WAT and BAT produce hormonal signals. WAT secretes leptin and tumor necrosis factor (TNF), that constitute regulatory signals for energy homeostasis and most probably for other physiological functions. 5 BAT is an extra-thyroidal source of T 3 , the biologically active form derived from the main product of the thyroid gland, T 4 . BAT T 3 production is modulated in parallel with the thermogenic status of the tissue and can be viewed as a signal to increase basal metabolic status in other tissues. 6 Moreover, recent studies have indicated that both adipose tissues, WAT and BAT, may play a key role in retinoid uptake, storage, mobilization and transport.
The liver is the main organ involved in the storage and homeostasis of retinoids; however, adipose tissues contain substantial amounts of retinol and retinyl esters, and it has been estimated that all adipose depots could account for 15 ± 20% of the total body retinoid stores. 7 Retinoids accumulate in adipocytes rather than in stromal-vascular cells 7 and differentiation of precursor cells into white or brown adipocytes is associated with accumulation of intracellular retinoids. 8 Adipose tissue retinoid stores may be derived from two different sources. First, retinol can be provided by the lipoprotein lipase hydrolysis of the retinyl esters contained in postprandial chylomicrons. 9 It is considered that this pathway is especially important in both WAT and BAT. Second, retinol can be taken up by cells from the bloodstream where it is transported by retinol-binding protein (RBP). RBP forms a protein complex with another plasma protein, transthyretin. 10 Holo-RBP delivers retinol to target cells via the cellular retinol-binding protein (CRBP), also believed to be crucial in retinol metabolism, as the retinol-CRBP complex is considered the optimal substrate for either retinol esteri®cation or oxidation to RA. 11 Interestingly, CRBP and RBP are highly expressed in both WAT and BAT. 7 Moreover, brown and white adipocytes synthesize RBP in vitro and secrete it into the culture medium 7 and retinol can also be mobilizated from adipocytes. 12 Thus, taken together, these data suggest that adipose tissues regulate retinoid homeostasis, as they are involved not only in retinol uptake and storage, but also in its mobilization and transport.
As stated in the introduction, most of the effects of retinoids are mediated by its active form, RA. Different adipose depots contain RA at concentrations similar to those determined in liver and in other RA-responsive tissues. 13 Thus, considering the total mass of adipose tissues, they may be quantitatively important for RA metabolism. In relation to the origin of the RA present in adipose tissues, it has been estimated that RA is derived mainly from local synthesis. 13 It is considered that retinol is enzymatically oxidized to RA by mechanisms similar to those acting in other retinoid-sensitive tissues. 14, 15 In addition, systemic RA, which circulates in plasma bound to albumin, also contributes to the RA present in the adipose tissue.
13 Figure 1 depicts the pathways of generation for active forms of retinoids.
Adipose tissues have long been recognized as a potential site for RA action, and retinoid receptors belonging to the two different subfamilies, RAR and RXR, are expressed in adipose tissues. 16, 17 However, WAT and BAT show a differential pattern of expression for RAR and RXR subtypes: at the mRNA level, RARa, RARg and RXRa are highly expressed in WAT depots, whereas RARb and RXRg are poorly expressed. In contrast, both RARb and RXRg mRNAs are abundant in BAT, while RARa, RARg and RXRa are expressed at lower levels in BAT than in WAT. 18 The characteristic pro®le of expression of RAR and RXR subtypes in BAT vs WAT is the same in several mammalian species, from rodents to the baboon. 18 Thus, the conservation of the expression pattern of retinoid receptors in WAT vs BAT suggests a speci®c function for the various retinoid receptor subtypes in the control of gene expression in white and brown adipocytes. Although the speci®c role of the different receptors subtypes in WAT with respect to BAT has not been studied, it has been described that the targeted disruption of particular RXR and RAR subtypes, either alone or in combination, causes complex effects in the development of other tissues and in morphogenesis. 19 
Retinoic acid and adipocyte differentiation
In 1980, RA was ®rst recognized as a potent inhibitor of adipocyte differentiation. 20 When pre-adipose cells from different cell lines such as 3T3-L1 or 3T3-F442A are exposed to all-trans RA at concentrations ranging from 3 nM to 10 mM, the appearance of the Retinoids and adiopose tissues F Villarroya et al characteristic features of the white adipose cell phenotype is blunted. 20 ± 22 Lipid accumulation is suppressed and molecular markers of adipocyte differentiation such as adipocyte lipid-binding protein or stearoylCoA desaturase mRNAs 22 are down-regulated. The effects of RA on the adipose cells have however two particular features. First, addition of RA to cell cultures is only effective in blocking cell differentiation when performed at early stages of the process. 22, 23 Second, the analysis of marker genes, whose expression is characteristic of the differentiated phenotype of adipocytes, does not provide evidence of direct effects of RA on gene transcription through potential`negative RA responsive elements'.
The differentiation program of the white adipocyte, has been extensively studied in cell cultures and several transcription factors have been identi®ed which act sequentially and cooperatively to trigger adipocyte-speci®c gene expression and elicit the acquisition of the adipocyte phenotype. Basically, the induction of adipocyte differentiation involves the interplay of members of the CAATaenhancer binding protein (CaEBP) and PPAR families of transcription factors. CaEBP proteins are members of the b-ZIP family of transcription factors, whereas PPARs are a subgroup of nuclear hormone receptors. Several lines of evidence indicate that adipocyte differentiation involves induction of the transcription factor CaEBPb followed by induction of PPARg and ®nally CaEBPa. A complex interplay of regulation for expression of the three corresponding genes, is considered to lead to the synergistic action of PPARg and CaEBPa that activates adipocyte-speci®c genes. The whole process has recently been reviewed. 24 How RA interferes with this process and blocks adipogenesis is not fully understood. RA is unable to block adipogenesis if CaEBPa has already been induced. 25 On the other hand, RA does not affect the early induction of CaEBPb, but it blocks the induction of CaEBPa and it is a potent inhibitor of PPARg expression. 25 Thus, it is proposed that RA blocks CaEBPb-dependent activation of expression of PPARg and CaEBPa, which leads to inhibition of adipose differentiation. The lack of sensitivity of pre-adipose cells to inhibition of adipogenesis, in the late stages of differentiation, is explained by the fact that such a mechanism does not operate when the expression of CaEBPa and PPARg has been induced. This proposal is schematized in Figure 2 . The mechanism for this effect of RA remains unknown. It has been established that activation of RAR receptors, especially the RARa isoform, 26 is required for this process, but binding of RAR to DNA target sequences does not appear to be required. 25 On the other hand, the down-regulation of RARa and RARg expression that occurs during adipocyte differentiation, 17 appears to contribute to this desensitation to RA of differentiated adipose cells. RA action also affects other signalling pathways that might contribute to impaired adipogenesis. Thus, RA causes a sustained rise in the expression of cjun in adipocyte precursor cells, a transcription factor with anti-adipogenic properties. 27 RA also causes a down-regulation of thyroid hormone receptors in association with inhibition of Ob17 adipogenic differentiation 28 and this might contribute to inhibition of adipocyte differentiation considering the positive action of thyroid hormones on adipogenesis. Moreover, RA has been reported to downregulate the expression of molecular markers of adipogenesis such as adipsin 29 or lipoprotein lipase, 30 through post-transcriptional mechanisms that await characterization.
The physiological role of the inhibition by RA of adipocyte differentiation has been questioned by observations that the effect of low doses (1 ± 10 nM) of all-trans RA on adipogenesis changes from inhibitory to enhancing. 31, 32 It has been argued that these concentrations are in the range of estimates of RA concentration in adipose tissues 13 and of the Kd values of RARs for all-trans RA 33 and therefore they are more likely to be related to the concentrations of the retinoic acid to which the cell nuclei are exposed during development and differentiation. However, the molecular mechanisms by which low concentrations of RA stimulate adipogenesis, have not been determined. On the other hand, recent ®ndings point out that retinoids selectively activating RXR receptors promote adipogenesis. 34 The PPARaRXR complex is dependent on ligand activation not only of PPARg but also of RXR. 35 9-cis RA can activate both RAR and RXR receptors and all-trans RA is able to isomerize to 9-cis RA in most cells studied so far. 36 It appears that the resulting effects of retinoids on adipose differentiation depend on a complex balance between RA metabolism and relative RAR and RXR receptor availability in the cell. In fact, expression of RXR isoforms is up-regulated during adipocyte differentiation. 37 In addition, reduced RAR expression may allow RXR to form heterodimers with PPARg instead of RXRaRAR dimers. The action of RA on brown adipocytes has speci®c features, since it promotes the expression of the gene for uncoupling protein-1 (ucp-1), the mitochondrial protein that confers its speci®c thermogenic function to BAT. 38 The potency of RA inducing ucp-1 expression, is as high as that of noradrenaline, the classical agent stimulating ucp-1 gene expression in response to sympathetic activity and thermogenic requirements. 38 The action of RA on the ucp-1 gene occurs through pathways distinct from adrenergic regulation and does not require protein synthesis. 38 The expression of ucp-1 gene is controlled by two regions upstream from the transcription initiation site: a proximal regulatory region and a distal enhancer, which are required for hormonal and differentiation-dependent regulation (see Figure 3) . RA stimulates ucp-1 gene transcription through a`retinoid responsive region' in the distal enhancer.
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The mechanisms of action of RA on the ucp-1 gene, involve a complex array of RA isomers, retinoid receptors and gene elements. Activation of both RAR-and RXR-dependent pathways contributes to the induction of the ucp-1 gene by retinoids, as shown by the action of selective agonists of both types of receptor and the ability of overexpressed receptors to enhance responsiveness to retinoids. 38, 41 Moreover, each subtype of the receptors RAR or RXR has a different capacity to mediate the action of retinoids on the ucp-1 gene. 41 At least three sites inside thè retinoid responsive region' may contribute to the RA effects. An upstream region contains a binding site for PPARaRXR heterodimers, potentially sensitive to 9-cis RA activation of the RXR moiety. 42 A central region contains binding sites for RAR and RXR and has been described to mediate responsiveness to all-trans RA and 9-cis RA. However, these sites do not ®t with either RAR-or RXR-dependent canonical DNA sequences for RA-response elements and their precise architecture has not been established. 39, 40 A third downstream region binds thyroid hormone receptor, as well as RXR, even though there is no evidence of its involvement in mediating retinoid stimulation through RXR activation. 38, 43 Figure 3 summarizes the present knowledge on the mechanisms of action of RA on the transcription of the ucp-1 gene, based on studies of the corresponding rat and mouse genes.
Conclusion
Even though the action of RA promoting ucp-1 expression has been observed in mice treated with pharmacological doses of retinoids, 44 the physiological signi®cance of this effect is unknown. BAT is a site for diet-induced thermogenesis and further research is needed to determine the effect of vitamin A-related nutrients on this function. In fact, carotenoids have been reported to mimic the action of RA on ucp-1 expression in brown adipocytes. 45 Furthermore, the molecular mechanisms for the initiation of ucp-1 gene expression during ontogeny, which occurs before birth in most species, have not been established and appear to be independent of adrenergic stimulation. RA is a potent morphogen in mammals and its potential involvement in the ®rst induction of ucp-1 gene transcription deserves future research. Retinoids and adiopose tissues F Villarroya et al
